Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.97EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.97ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.97ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.97EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.97EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.97ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.97ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CH.1.1.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CH.1.1.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-22471.2China
CH.1.1.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FE.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FE.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FE.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FE.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.3.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.3.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.3.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.3.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used